Rob F. Walker

693 total citations
24 papers, 300 citations indexed

About

Rob F. Walker is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rob F. Walker has authored 24 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Internal Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rob F. Walker's work include Venous Thromboembolism Diagnosis and Management (12 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Blood Pressure and Hypertension Studies (5 papers). Rob F. Walker is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (12 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Blood Pressure and Hypertension Studies (5 papers). Rob F. Walker collaborates with scholars based in United States, Norway and United Kingdom. Rob F. Walker's co-authors include Pamela L. Lutsey, Álvaro Alonso, Neil A. Zakai, Richard F. MacLehose, Terrence J Adam, Logan Cowan, Faye L. Norby, Nicholas S. Roetker, Lin Y. Chen and Naomi Hudson and has published in prestigious journals such as Circulation, American Journal of Epidemiology and Mayo Clinic Proceedings.

In The Last Decade

Rob F. Walker

20 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob F. Walker United States	8	135	123	66	33	30	24	300
Mariola Ropacka‐Lesiak Poland	11	40 0.3×	37 0.3×	8 0.1×	6 0.2×	62 2.1×	50	398
Sally Greenberg United States	7	239 1.8×	50 0.4×	22 0.3×	24 0.7×	157 5.2×	8	372
Duo Huang China	13	237 1.8×	94 0.8×	14 0.2×	5 0.2×	41 1.4×	32	373
Hatice Ender Soydinç Türkiye	12	42 0.3×	8 0.1×	13 0.2×	14 0.4×	51 1.7×	37	457
E Carty United Kingdom	9	28 0.2×	37 0.3×	5 0.1×	84 2.5×	65 2.2×	18	365
Branavan Sivapathasundaram Canada	9	80 0.6×	7 0.1×	48 0.7×	32 1.0×	122 4.1×	15	299
Yanming Li China	11	92 0.7×	9 0.1×	17 0.3×	8 0.2×	40 1.3×	41	335
Stephanie Padberg Germany	12	25 0.2×	7 0.1×	56 0.8×	11 0.3×	32 1.1×	28	321
Małgorzata Chlabicz Poland	10	79 0.6×	14 0.1×	20 0.3×	4 0.1×	23 0.8×	36	178
Conor‐James MacDonald France	10	60 0.4×	7 0.1×	17 0.3×	7 0.2×	13 0.4×	23	227

Countries citing papers authored by Rob F. Walker

Since Specialization

Citations

This map shows the geographic impact of Rob F. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob F. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob F. Walker more than expected).

Fields of papers citing papers by Rob F. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob F. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob F. Walker. The network helps show where Rob F. Walker may publish in the future.

Co-authorship network of co-authors of Rob F. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Rob F. Walker. A scholar is included among the top collaborators of Rob F. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob F. Walker. Rob F. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sedaghat, Sanaz, Rob F. Walker, Jialing Liu, et al.. (2025). Proteomics-based aging clocks in midlife or late-life and their associated risk of dementia. Communications Medicine. 5(1). 353–353.

Lutsey, Pamela L., Rob F. Walker, Wendy Wang, et al.. (2025). Infection‐Related Hospitalization and Incident Heart Failure in MarketScan: A Case‐Crossover Study. Journal of the American Heart Association. 14(11). e039123–e039123.

Prizment, Anna E., et al.. (2024). Cardiovascular Disease With Hormone Therapy and Ovarian Suppression in Premenopausal Breast Cancer Survivors. JACC CardioOncology. 6(6). 907–918. 4 indexed citations

Walker, Rob F., Neil A. Zakai, Richard F. MacLehose, et al.. (2024). Association of anticoagulant choice with death in the primary treatment of noncancer venous thromboembolism: Medicare 2011-2018. American Journal of Epidemiology. 194(3). 699–708.

Wang, Wendy, Lin Y. Chen, Rob F. Walker, et al.. (2024). Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries. Pharmacoepidemiology and Drug Safety. 33(4). e5786–e5786.

Walker, Rob F., Neil A. Zakai, Susan M. Mason, et al.. (2023). Autoimmune disease and risk of postpartum venous thromboembolism. Research and Practice in Thrombosis and Haemostasis. 7(2). 100091–100091. 2 indexed citations

Walker, Rob F., Richard F. MacLehose, Diego Adrianzen Herrera, et al.. (2023). Venous thromboembolism mortality and trends in older US adults, 2011–2019. American Journal of Hematology. 98(9). 1364–1373. 9 indexed citations

Wang, Wendy, Lin Y. Chen, Rob F. Walker, et al.. (2023). SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes. Mayo Clinic Proceedings. 98(7). 985–996. 4 indexed citations

Chang, Kevin Y., Rob F. Walker, Kurt W. Prins, et al.. (2023). Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension. Journal of the American Heart Association. 12(6). e027559–e027559. 5 indexed citations

10.

Walker, Rob F., Neil A. Zakai, Richard F. MacLehose, et al.. (2023). Abstract P625: Differences in Urban/Rural Oral Anticoagulation and Mortality Among People With Incident Venous Thromboembolism: Medicare 20% Sample 2016-2018. Circulation. 147(Suppl_1). 1 indexed citations

11.

Lutsey, Pamela L., Thenappan Thenappan, Kurt W. Prins, et al.. (2022). Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database. Journal of the American Heart Association. 11(14). e024358–e024358. 10 indexed citations

12.

Alonso, Álvaro, Faye L. Norby, Richard F. MacLehose, et al.. (2021). Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism. Journal of the American Heart Association. 10(18). e021227–e021227. 4 indexed citations

13.

Norby, Faye L., Pamela L. Lutsey, Nathan D. Shippee, et al.. (2021). Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries. American Journal of Cardiovascular Drugs. 22(2). 207–217. 19 indexed citations

14.

Zakai, Neil A., Rob F. Walker, Richard F. MacLehose, et al.. (2021). Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis. Research and Practice in Thrombosis and Haemostasis. 5(6). e12575–e12575. 4 indexed citations

15.

MacLehose, Richard F., Neil A. Zakai, Rob F. Walker, et al.. (2021). Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding. Research and Practice in Thrombosis and Haemostasis. 5(4). e12514–e12514. 4 indexed citations

16.

Lutsey, Pamela L., Rob F. Walker, Richard F. MacLehose, et al.. (2019). Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017. Research and Practice in Thrombosis and Haemostasis. 3(4). 668–673. 57 indexed citations

17.

Walker, Rob F., Neil A. Zakai, Richard F. MacLehose, et al.. (2019). Abstract P311: Testosterone Therapy and Risk of Venous Thromboembolism Among Men Without Hypogonadism. Circulation. 139(Suppl_1). 1 indexed citations

18.

Lutsey, Pamela L., Neil A. Zakai, Richard F. MacLehose, et al.. (2019). Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism. British Journal of Haematology. 185(5). 903–911. 33 indexed citations

19.

Walker, Rob F., Annette Hayden, Maria do Céu Machado, et al.. (2019). Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma Pre-Treatment Biopsies. European Journal of Surgical Oncology. 45(11). 2212–2212. 1 indexed citations

20.

Hudson, Naomi, Edward J. Kasner, John Beckman, et al.. (2013). Characteristics and magnitude of acute pesticide‐related illnesses and injuries associated with pyrethrin and pyrethroid exposures—11 states, 2000–2008. American Journal of Industrial Medicine. 57(1). 15–30. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact